Free shipping on all orders over $ 500

INK128 (MLN0128)

Cat. No. M2151
INK128 (MLN0128) Structure


Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM/1mL In DMSO USD 105 In stock
2mg USD 63 In stock
5mg USD 95 In stock
10mg USD 110 In stock
25mg USD 240 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

INK128 (also known as MLN0128) is also an orally bioavailable mTOR inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. INK128 blocks the phosphorylation of downstream substrates of both TORC1 and TORC2. INK128 (MLN0128) exhibits an enzymatic inhibition activity against mTOR and more than 100-fold selectivity to PI3K kinases. INK128 interferes with the growth of cell lines which are resistant to rapamycin and pan-PI3K inhibitors. Oral administration of INK128 (MLN0128) inhibits angiogenesis and tumor growth in several xenograft models. In vitro and in vivo studies showed that p-4EBP1 and p-Akt inhibition could be predictive markers of TORC2 inhibition in MM cell lines. Dual TORC1/2 inhibition showed better inhibition of adhesion to BM microenvironmental cells and inhibition of homing in vivo.

Product Citations
Customer Product Validations & Biological Datas
Source Clinical Cancer Research (2018 Nov). Figure 2. MLN0128 (Abmole Bioscience)
Method Western blotting
Cell Lines PC9, HCC4006 and HCC827 cells
Concentrations 200 nM
Incubation Time -
Results Consistently, MCL-1 levels were decreased in both AZD2014 and MLN0128-treated cells.
Source Cancer Biology & Therapy (2015). Figure 1. INK-128
Method MTT assay
Cell Lines HT-29 cells
Concentrations 5, 25 and 100 nM
Incubation Time 72 h
Results INK-128 dose-dependently inhibited the number of survival colonies, while increasing the PtdIns staining in HT-29 cells.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 309.33
Formula C15H15N7O
CAS Number 1224844-38-5
Purity >99%
Solubility DMSO 60 mg/mL
Storage at -20°C

Defining the role of TORC1/2 in multiple myeloma.
Maiso P, et al. Blood. 2011 Dec 22;118(26):6860-70. PMID: 22045983.

Related mTOR Products
LY303511 hydrochloride

LY303511 hydrochloride is a structural analogue of LY294002. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.


MHY1485 is an mTOR activator that potently inhibits autophagy by suppression of fusion between autophagosomes and lysosomes.


CZ415 is a potent ATP-competitive mTOR inhibitor with very good cell permeability.


GNE-477 is a potent and efficacious dual PI3K (IC50=4 nM)/mTOR(Ki=21 nM) inhibitor.


Zotarolimus (ABT-578) is an analogue of rapamycin, and inhibits FKBP-12 binding with IC50 of 2.8 nM.

Abmole Inhibitor Catalog 2017

Keywords: INK128 (MLN0128), MLN0128 supplier, mTOR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.